Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › West Reading › NPI 1669530069
Physician

Reading Hospital

Reading Hospital was paid $58.34M by Medicaid between Jan 2018 and Dec 2024, across 572 billing codes. Its largest line is 99284, emergency room visit (serious) — 17% of everything it billed.

33Billing provider infoREADING HOSPITAL
WEST READING, PA 19611
33aNPI1669530069assigned 12/05/2006
33bProvider typeSurgery Physician
28Total paid$58.34M
24GClaims1,585,847
24DCodes billed572
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Surgery Physician providers in Pennsylvania

Rank by total paid#1 of 190
Median peer was paid$3K
This provider vs. median17,496×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official EHINGER, ROBERT controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M$3.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20182,991$353K
201919,469$581K
2020194,105$6.71M
2021632,476$23.35M
2022260,209$10.19M
2023267,255$9.65M
2024incomplete209,342$7.50M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 17% 72,852 70,302 $9.81M
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 11% 117,147 92,226 $6.63M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 7.4% 48,717 46,790 $4.31M
G0378 Hospital observation service, per hour 6.4% 3,844 3,572 $3.76M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 5.4% 32,425 31,569 $3.12M
90834 Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient 4.1% 37,963 22,028 $2.40M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 4.0% 14,058 13,189 $2.36M
87631 3.4% 13,573 13,334 $1.96M
X0621 2.4% 6,150 3,677 $1.38M
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 1.4% 7,920 7,227 $791K
99215 Doctor's office visit, returning patient (complex)Prolong outpt/office vis 1.2% 10,601 8,012 $715K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 1.2% 6,622 6,579 $692K
560 more codes
J9271 Injection, pembrolizumab, 1 mg 1.1% 223 $631K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.1% 4,045 $617K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 9,490 $539K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 18,108 $502K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 17,640 $502K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 4,406 $468K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 91,132 $466K
80053 Comprehensive metabolic panel <1% 43,689 $457K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 7,088 $323K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 15,560 $313K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 3,183 $309K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 10,537 $305K
99213 Doctor's office visit, returning patient (routine) <1% 17,296 $304K
71046 Radiologic examination, chest; 2 views <1% 19,926 $303K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 33,040 $297K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 3,305 $277K
87536 <1% 2,465 $276K
G9012 Other specified case management service not elsewhere classified <1% 1,200 $262K
87481 <1% 3,853 $260K
70450 Computed tomography, head or brain; without contrast material <1% 4,380 $259K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 8,132 $259K
80050 General health panel <1% 4,891 $247K
95811 <1% 477 $244K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 2,361 $243K
90832 Psychotherapy session, about 30 minutes <1% 6,346 $230K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 828 $230K
99214 Doctor's office visit, returning patient (more involved) <1% 6,650 $227K
80048 Basic metabolic panel (calcium, ionized) <1% 24,296 $211K
80061 Lipid panel <1% 14,322 $203K
71275 Computed tomographic angiography, chest, with contrast material <1% 1,136 $198K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 4,780 $179K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 3,023 $176K
87086 Culture, bacterial; quantitative colony count, urine <1% 21,317 $172K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 1,654 $167K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,863 $163K
84443 Thyroid stimulating hormone (TSH) <1% 7,673 $161K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 3,835 $155K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 4,081 $151K
90792 Psychiatric diagnostic evaluation with medical services <1% 681 $138K
86360 <1% 2,173 $137K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 11,630 $133K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 4,659 $132K
96375 Therapeutic injection; each additional sequential IV push <1% 7,860 $132K
J7298 Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg <1% 432 $131K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 576 $127K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 3,928 $127K
J7307 Etonogestrel (contraceptive) implant system, including implant and supplies <1% 439 $120K
84484 <1% 15,742 $119K
86780 <1% 7,471 $119K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 1,671 $114K
93975 <1% 977 $110K
90853 Group psychotherapy (other than of a multiple-family group) <1% 2,979 $109K
62323 <1% 344 $107K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 1,822 $107K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 4,927 $106K
86359 <1% 2,174 $103K
78815 Positron emission tomography (PET) for limited area imaging <1% 128 $101K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 5,344 $99K
G0008 Administration of influenza virus vaccine <1% 12,549 $97K
87480 <1% 3,945 $96K
76830 Ultrasound, transvaginal <1% 2,020 $96K
36415 Collection of venous blood by venipuncture <1% 17,558 $92K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 501 $91K
96361 Intravenous infusion, hydration; each additional hour <1% 7,438 $90K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 1,130 $90K
82248 <1% 15,443 $89K
84702 <1% 5,021 $86K
83735 <1% 15,978 $86K
87660 <1% 3,565 $85K
81003 <1% 26,588 $85K
J1750 Injection, iron dextran, 50 mg <1% 3,634 $82K
Q5108 Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg <1% 91 $81K
72125 Computed tomography, cervical spine; without contrast material <1% 1,405 $80K
82728 <1% 6,791 $79K
81001 <1% 26,691 $78K
83970 <1% 1,754 $76K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 1,446 $74K
86803 <1% 3,706 $72K
87150 <1% 1,557 $70K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 1,110 $69K
T1001 Nursing assessment / evaluation <1% 1,002 $69K
83036 Hemoglobin; glycosylated (A1C) <1% 10,172 $67K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 3,463 $65K
99188 <1% 3,336 $65K
90847 Family psychotherapy with the patient present, 50 minutes <1% 1,273 $64K
70551 Magnetic resonance imaging, brain; without contrast material <1% 307 $64K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 1,159 $63K
J7030 Infusion, normal saline solution , 1000 cc <1% 22,397 $62K
87510 <1% 3,633 $62K
77066 Tomosynthesis, mammo <1% 706 $62K
81513 <1% 947 $60K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 390 $57K
93971 <1% 948 $54K
82607 <1% 4,372 $54K
H0039 Assertive community treatment, face-to-face, per 15 minutes <1% 514 $53K
81025 <1% 13,323 $51K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,443 $51K
J1745 Injection, infliximab, excludes biosimilar, 10 mg <1% 87 $51K
76642 <1% 1,229 $51K
97162 <1% 1,156 $49K
G0009 Administration of pneumococcal vaccine <1% 6,279 $48K
85610 <1% 15,016 $47K
83880 <1% 1,730 $46K
74183 <1% 128 $46K
99429 <1% 228 $46K
90651 <1% 978 $45K
88342 <1% 1,082 $44K
92551 <1% 4,742 $44K
58558 <1% 66 $43K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 222 $43K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,789 $41K
97161 <1% 1,139 $41K
72141 <1% 189 $40K
77065 Tomosynthesis, mammo <1% 544 $38K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,616 $37K
99173 <1% 5,625 $37K
86850 <1% 4,765 $37K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 247 $36K
96376 <1% 1,255 $36K
86762 <1% 1,898 $36K
76770 <1% 884 $36K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 810 $35K
83540 <1% 4,240 $35K
90715 <1% 2,917 $35K
70496 <1% 264 $35K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,047 $35K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 93 $34K
85730 <1% 5,963 $34K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,803 $34K
87340 <1% 2,368 $33K
76536 <1% 701 $33K
83655 <1% 3,635 $33K
86480 <1% 426 $33K
86618 <1% 642 $32K
87040 <1% 1,989 $31K
85027 <1% 4,388 $31K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 17,996 $30K
83690 <1% 6,718 $30K
H2010 Comprehensive medication services, per 15 minutes <1% 1,607 $29K
87512 <1% 1,676 $29K
J0897 Injection, denosumab, 1 mg <1% 53 $28K
93970 <1% 391 $28K
71250 <1% 477 $28K
76819 Fetal biophysical profile; without non-stress testing <1% 481 $27K
88142 <1% 1,608 $27K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 1,591 $27K
49083 <1% 153 $27K
70498 <1% 202 $25K
82550 <1% 4,311 $25K
84439 <1% 2,978 $24K
82746 <1% 2,052 $24K
82570 <1% 3,186 $23K
96417 <1% 389 $22K
87186 <1% 2,642 $22K
74019 <1% 1,225 $21K
72110 <1% 1,015 $21K
87077 <1% 2,757 $20K
84403 <1% 681 $20K
64615 <1% 184 $20K
76820 <1% 760 $19K
M0239 Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring <1% 82 $19K
96415 <1% 584 $19K
90686 <1% 2,907 $19K
84630 <1% 1,312 $19K
86901 <1% 4,765 $18K
86900 <1% 4,819 $18K
82565 <1% 3,478 $18K
84146 <1% 675 $18K
73564 <1% 925 $18K
84134 <1% 891 $18K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 46 $18K
83550 <1% 3,584 $17K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 8,470 $17K
82950 <1% 2,424 $17K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 863 $17K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 323 $17K
71045 Radiologic examination, chest; single view <1% 2,881 $17K
84450 <1% 2,639 $16K
58661 <1% 19 $16K
87522 Neg quan hep c or qual rna <1% 396 $16K
J2785 Injection, regadenoson, 0.1 mg <1% 379 $16K
12011 <1% 167 $16K
83605 <1% 2,594 $16K
93017 <1% 461 $16K
84153 <1% 692 $16K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 352 $15K
86140 <1% 4,538 $15K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 74 $15K
77062 <1% 642 $14K
73610 <1% 758 $14K
77336 <1% 411 $14K
83525 <1% 1,070 $14K
96411 <1% 253 $14K
76870 <1% 319 $14K
S9470 Nutritional counseling, dietitian visit <1% 430 $14K
82043 <1% 1,579 $13K
86038 <1% 796 $13K
82803 <1% 623 $13K
86787 <1% 616 $13K
58300 <1% 151 $13K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 732 $13K
93226 <1% 346 $13K
73030 <1% 866 $13K
74018 <1% 925 $12K
74178 <1% 55 $12K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 51 $12K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 2,701 $12K
84145 <1% 651 $12K
82962 <1% 6,838 $12K
85379 <1% 1,335 $12K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 2,307 $12K
82784 <1% 617 $12K
76885 <1% 116 $11K
J7120 Ringers lactate infusion, up to 1000 cc <1% 7,423 $11K
83520 <1% 586 $11K
84402 <1% 373 $11K
G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion <1% 1,111 $11K
90677 <1% 1,261 $11K
80076 <1% 1,217 $11K
82670 <1% 487 $11K
83516 <1% 340 $11K
12001 <1% 209 $11K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 121 $11K
73630 <1% 1,010 $11K
62321 <1% 28 $10K
J1815 Injection, insulin, per 5 units <1% 1,749 $10K
J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg <1% 2,025 $10K
44970 <1% 13 $10K
84460 <1% 1,381 $10K
80074 <1% 199 $10K
83615 <1% 1,621 $10K
84550 <1% 1,648 $10K
J2469 Injection, palonosetron hcl, 25 mcg <1% 1,816 $10K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 1,308 $10K
77061 <1% 432 $10K
84703 <1% 963 $10K
97597 <1% 457 $10K
86765 <1% 761 $10K
72156 <1% 50 $10K
83001 <1% 509 $10K
70486 <1% 144 $9K
Q9957 Injection, perflutren lipid microspheres, per ml <1% 425 $9K
J2790 Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) <1% 316 $9K
84425 <1% 1,230 $9K
84144 <1% 527 $9K
83021 <1% 423 $9K
85652 <1% 2,998 $9K
J3490 Unclassified drugs <1% 6,103 $9K
0001A <1% 497 $9K
73130 <1% 740 $8K
A9585 Injection, gadobutrol, 0.1 ml <1% 490 $8K
84481 <1% 333 $8K
73502 <1% 458 $8K
88112 <1% 282 $8K
82947 <1% 1,969 $8K
83013 <1% 117 $8K
87081 <1% 1,270 $8K
84100 <1% 1,758 $8K
72070 <1% 353 $7K
77080 <1% 125 $7K
85018 <1% 1,940 $7K
96367 <1% 657 $7K
70491 <1% 93 $7K
84156 <1% 1,599 $7K
85384 <1% 671 $7K
80164 <1% 378 $7K
87902 <1% 57 $7K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 294 $6K
0002A <1% 324 $6K
82330 <1% 973 $6K
93225 <1% 348 $6K
86706 <1% 424 $6K
72050 <1% 225 $6K
82652 <1% 148 $6K
86665 <1% 228 $6K
86696 <1% 157 $6K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 806 $6K
82553 <1% 663 $6K
88341 <1% 108 $6K
86003 <1% 70 $5K
84520 <1% 1,176 $5K
84590 <1% 374 $5K
83921 <1% 282 $5K
90732 <1% 253 $5K
97165 <1% 143 $5K
82627 <1% 230 $5K
82105 <1% 248 $5K
87493 <1% 123 $5K
87070 <1% 778 $5K
86695 <1% 158 $5K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient <1% 205 $5K
82525 <1% 351 $5K
87252 <1% 113 $5K
82247 <1% 660 $5K
83002 <1% 240 $4K
94762 <1% 93 $4K
72052 <1% 134 $4K
86800 <1% 210 $4K
86431 <1% 475 $4K
72158 <1% 37 $4K
87205 <1% 953 $4K
84165 <1% 326 $4K
97166 <1% 99 $4K
73110 <1% 356 $4K
73590 <1% 287 $4K
87799 <1% 304 $4K
87147 <1% 879 $4K
77412 <1% 119 $4K
84446 <1% 327 $4K
81002 <1% 1,205 $4K
87899 <1% 142 $4K
82310 <1% 512 $4K
82378 <1% 261 $4K
86039 <1% 222 $4K
93350 <1% 104 $4K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 177 $4K
82951 <1% 349 $3K
72100 <1% 180 $3K
71271 <1% 60 $3K
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring <1% 17 $3K
C1769 Guide wire <1% 360 $3K
93321 <1% 222 $3K
87015 <1% 352 $3K
94729 <1% 119 $3K
74022 <1% 140 $3K
82533 <1% 228 $3K
93296 <1% 288 $3K
93308 <1% 203 $3K
86334 <1% 147 $3K
83498 <1% 131 $3K
84132 <1% 747 $3K
58301 <1% 30 $3K
81511 <1% 29 $3K
86235 <1% 57 $3K
85014 <1% 1,074 $3K
73562 <1% 185 $3K
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion <1% 22 $3K
83721 <1% 267 $3K
80051 <1% 519 $3K
10060 <1% 60 $3K
86617 <1% 67 $3K
87253 <1% 85 $3K
78264 <1% 28 $3K
86664 <1% 132 $3K
86376 <1% 297 $3K
82800 <1% 296 $3K
82977 <1% 263 $2K
73080 <1% 235 $2K
84295 <1% 578 $2K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 4,989 $2K
99001 <1% 248 $2K
H0034 Medication training and support, per 15 minutes <1% 108 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 17,722 $2K
95816 <1% 186 $2K
84436 <1% 231 $2K
J7050 Infusion, normal saline solution, 250 cc <1% 23,682 $2K
94726 <1% 87 $2K
86255 <1% 121 $2K
86663 <1% 131 $2K
84480 <1% 248 $2K
73090 <1% 199 $2K
J0185 Injection, aprepitant, 1 mg <1% 39 $2K
J2270 Injection, morphine sulfate, up to 10 mg <1% 4,056 $2K
73552 <1% 132 $2K
90474 <1% 201 $2K
90621 <1% 45 $2K
90837 Psychotherapy session, about an hour <1% 14 $2K
86769 <1% 164 $2K
73700 <1% 40 $2K
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 1,275 $2K
90472 Immunization administration, each additional vaccine (list separately) <1% 270 $2K
77334 <1% 50 $2K
73560 <1% 153 $2K
90750 <1% 58 $2K
87045 <1% 265 $2K
88304 <1% 335 $2K
Q0114 Fern test <1% 173 $2K
82040 <1% 472 $2K
J1170 Injection, hydromorphone, up to 4 mg <1% 2,670 $2K
90682 <1% 369 $2K
96040 <1% 29 $2K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,266 $2K
96401 <1% 102 $2K
86708 <1% 103 $2K
70360 <1% 155 $2K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 36 $2K
88307 <1% 198 $2K
72040 <1% 97 $2K
86481 <1% 26 $2K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 64 $2K
73140 <1% 170 $1K
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 468 $1K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 8,279 $1K
76882 <1% 202 $1K
96160 <1% 2,677 $1K
76801 <1% 30 $1K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 158 $1K
82010 <1% 344 $1K
85045 <1% 290 $1K
87625 <1% 39 $1K
J3475 Injection, magnesium sulfate, per 500 mg <1% 2,900 $1K
11043 <1% 29 $1K
11982 <1% 12 $1K
72170 <1% 129 $1K
88346 <1% 79 $1K
86704 <1% 80 $1K
J2704 Injection, propofol, 10 mg <1% 7,154 $1K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 18 $1K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 27 $1K
90633 <1% 136 $1K
93880 <1% 26 $1K
72081 <1% 47 $1K
86160 <1% 34 $1K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,594 $1K
87272 <1% 54 $978.63
73060 <1% 98 $961.20
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 5,173 $931.49
59025 Fetal non-stress test <1% 176 $929.83
84160 <1% 137 $922.07
87046 <1% 269 $914.57
80178 <1% 117 $903.42
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 536 $894.79
90656 <1% 272 $884.98
96368 <1% 120 $877.66
90670 <1% 43 $845.78
99152 <1% 239 $825.50
90744 <1% 209 $825.39
76825 <1% 41 $761.47
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 2,826 $757.84
J0640 Injection, leucovorin calcium, per 50 mg <1% 21 $755.44
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 13,731 $750.81
80197 <1% 76 $738.39
87269 <1% 54 $733.67
J7060 5% dextrose/water (500 ml = 1 unit) <1% 1,844 $726.94
86225 <1% 42 $699.25
87088 <1% 84 $681.31
97163 <1% 13 $671.90
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 1,089 $661.56
86645 <1% 29 $650.92
84466 <1% 40 $647.31
J1630 Injection, haloperidol, up to 5 mg <1% 1,611 $611.01
12002 <1% 14 $607.31
72131 <1% 15 $600.60
J2060 Injection, lorazepam, 2 mg <1% 3,028 $598.76
86308 <1% 76 $598.70
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 2,716 $593.07
85007 <1% 127 $581.90
99406 <1% 204 $577.72
85460 <1% 57 $572.45
93325 <1% 15 $536.72
90734 <1% 132 $516.20
J0690 Injection, cefazolin sodium, 500 mg <1% 2,356 $510.75
83930 <1% 225 $497.35
87517 <1% 13 $493.74
99204 Doctor's office visit, new patient (more involved) <1% 65 $477.92
99153 Mod sedat endo service >5yrs <1% 253 $466.31
82785 <1% 31 $435.42
96523 <1% 28 $397.28
80177 <1% 35 $392.87
84305 <1% 14 $379.24
99203 Doctor's office visit, new patient (routine) <1% 61 $377.74
73522 <1% 17 $371.23
84155 <1% 111 $368.72
J1650 Injection, enoxaparin sodium, 10 mg <1% 3,163 $367.96
J3370 Injection, vancomycin hcl, 500 mg <1% 288 $361.80
86592 <1% 85 $356.00
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 25 $347.90
94760 <1% 225 $343.88
83010 <1% 27 $342.12
J8540 Dexamethasone, oral, 0.25 mg <1% 1,050 $340.19
94681 <1% 15 $338.93
J3480 Injection, potassium chloride, per 2 meq <1% 1,261 $331.39
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 52 $320.71
82140 <1% 89 $312.68
95819 <1% 26 $310.29
87102 <1% 32 $298.05
J3010 Injection, fentanyl citrate, 0.1 mg <1% 6,466 $297.76
82390 <1% 26 $293.84
J1644 Injection, heparin sodium, per 1000 units <1% 2,145 $293.59
87641 <1% 13 $277.92
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 3,467 $274.12
G0010 Administration of hepatitis b vaccine <1% 69 $266.30
0071A <1% 493 $265.00
J7042 5% dextrose/normal saline (500 ml = 1 unit) <1% 1,512 $264.48
80069 <1% 47 $260.34
94010 <1% 42 $259.50
86580 <1% 47 $258.12
86644 <1% 13 $257.19
85041 <1% 75 $256.70
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 544 $244.11
87209 <1% 13 $235.25
82103 <1% 12 $228.65
94060 <1% 24 $218.67
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 1,896 $217.59
43775 <1% 12 $211.72
82150 <1% 40 $210.20
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 644 $181.36
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 100 $179.34
96402 <1% 15 $166.72
J1030 Injection, methylprednisolone acetate, 40 mg <1% 294 $161.51
81050 <1% 31 $160.29
OP250 <1% 90 $140.66
J1953 Injection, levetiracetam, 10 mg <1% 18 $135.12
74220 <1% 12 $133.69
0072A <1% 464 $132.00
C9113 Injection, pantoprazole sodium, per vial <1% 253 $102.62
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 3,078 $99.82
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 8,256 $99.37
88302 <1% 31 $93.95
87075 <1% 13 $91.60
87177 <1% 13 $87.85
73660 <1% 14 $76.59
J0692 Injection, cefepime hydrochloride, 500 mg <1% 39 $72.29
77001 <1% 16 $56.83
0003A <1% 12 $44.00
96161 <1% 4,263 $42.61
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm <1% 334 $41.25
85651 <1% 15 $40.65
96127 <1% 1,845 $29.68
J3411 Injection, thiamine hcl, 100 mg <1% 14 $18.39
99441 <1% 14 $18.00
88300 <1% 26 $16.29
J7510 Prednisolone oral, per 5 mg <1% 32 $15.15
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 716 $14.16
J1940 Injection, furosemide, up to 20 mg <1% 21 $8.38
99205 Prolong outpt/office vis <1% 25 $0.01
J1756 Injection, iron sucrose, 1 mg 0% 807 $0.00
0124A 0% 188 $0.00
J0585 Injection, onabotulinumtoxina, 1 unit 0% 706 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 172 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 592 $0.00
J2323 Injection, natalizumab, 1 mg 0% 42 $0.00
J0137 Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg 0% 24 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 232 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 268 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 696 $0.00
J9217 Leuprolide acetate (for depot suspension), 7.5 mg 0% 14 $0.00
91320 0% 201 $0.00
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units 0% 23 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 90 $0.00
J0736 Injection, clindamycin phosphate, 300 mg 0% 14 $0.00
J3105 Injection, terbutaline sulfate, up to 1 mg 0% 13 $0.00
J9190 Injection, fluorouracil, 500 mg 0% 23 $0.00
J7606 Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms 0% 73 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 0% 13 $0.00
3046F 0% 38 $0.00
90619 0% 140 $0.00
90673 0% 21 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 0% 27 $0.00
0051A 0% 523 $0.00
90480 0% 140 $0.00
90375 0% 26 $0.00
00000 0% 9,376 $0.00
90698 0% 229 $0.00
A9150 Non-prescription drugs 0% 101 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 327 $0.00
0082A 0% 12 $0.00
3044F 0% 14 $0.00
0052A 0% 47 $0.00
J0561 Injection, penicillin g benzathine, 100,000 units 0% 26 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialEHINGER, ROBERT (SR VP FINANCIAL OPERATIONS)
Same official

Other billing entities under EHINGER, ROBERT

Full network →
ProviderLocationPaid
STC Pediatrics LLCPhiladelphia, PA$12.21M
STC Pediatrics LLCPhiladelphia, PA$8.73M
Tower Health Medical GroupWest Reading, PA$7.99M
Tower Health Medical GroupWest Reading, PA$2.54M
Chestnut Hill Clinic Company, LLCPhiladelphia, PA$2.28M
STC Pediatrics LLCPhiladelphia, PA$2.14M
STC Pediatrics LLCPhiladelphia, PA$2.04M
Tower Direct LLCWest Reading, PA$1.95M
STC Pediatrics LLCPhiladelphia, PA$1.82M
STC Pediatrics LLCPhiladelphia, PA$1.18M
STC Pediatrics LLCPhiladelphia, PA$997K
STC Pediatrics LLCJenkintown, PA$836K
Tower Health Medical GroupWest Reading, PA$835K
STC Pediatrics LLCPhiladelphia, PA$795K
STC Pediatrics LLCPhiladelphia, PA$784K
Tower Health Medical GroupWyomissing, PA$733K
STC Pediatrics LLCPhiladelphia, PA$711K
Tower Health Medical GroupReading, PA$698K
Tower Health Medical GroupWest Reading, PA$613K
STC Pediatrics LLCPhiladelphia, PA$502K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.